Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isoxazole derivatives as inducers of fetal hemoglobin in erythroid precursor cells from beta-thalassemic patients

Isoxazole derivatives as inducers of fetal hemoglobin in erythroid precursor cells from beta-thalassemic patients

US Patent 11077116 · Granted Aug 3, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnostic and therapeutic application of CTL and NK functionally selected cells2016
Compounds for use in the treatment of disorders that are ameliorated by inhibiti2016
Method of making and administering quinoline derivatives as anti-cancer agents2016
Trimethylangelicin as CFTR corrector in bronchial epithelial cells2016
Aryl isoxazole compounds with antitumoural activities2013
Stilbene derivatives as new cancer therapeutic agents2010
Double-stranded synthetic oligonucleotides useful for inducing apoptosis of oste2010
Use of angelicin and of its structural analogues for the treatment of thalassemi2009
Use of angelicin and of its structural analogues for the treatment of thalassemi2009
Use of rapamycin and structural analogues thereof2009
Heterocyclic and benzoheterocyclic polyamides structurally related to the natura2008
Synthetic oligonucleotides as inducers of erythroid differentiation2007